NEW YORK (GenomeWeb) – Episona announced today that it has raised approximately $4 million in seed financing to support the expansion of its first commercial product, Seed — an epigenetic test for male infertility and embryo quality.
NEW YORK (GenomeWeb) – Episona announced today that it has raised approximately $4 million in seed financing to support the expansion of its first commercial product, Seed — an epigenetic test for male infertility and embryo quality.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.